<DOC>
	<DOCNO>NCT00999102</DOCNO>
	<brief_summary>Beta-blockers prescribe million people treatment hypertension . Fatigue recognize common side effect beta-blockers significant effect quality life . Worse , many people take beta-blocker year even aware reduction energy living . A new vasodilating beta-blocker , nebivolol , approved FDA treatment hypertension , appear far less associated fatigue currently available beta-blockers . The purpose study compare nebivolol current best-selling beta-blocker , metoprolol , determine whether significant difference side effect include fatigue , reduce exertion tolerance , reduce quality life . In study , 30 subject take 2 study drug 8 week , consist 4 week low dose , 4 week ata high dose . All dosages FDA-approved treatment hypertension . Subjects investigator know drug administer completion study . Subjects undergo treadmill stress test complete fatigue quality life questionnaires 4 week treatment . An echocardiogram non-invasive measurement aortic blood pressure perform 8 week drug . Also , blood drawn store possible measurement drug level , 4 8 week drug . Results drug compare . If nebivolol find cause significantly less fatigue , would substantial importance many million people life-long beta-blocker therapy , live reduce energy .</brief_summary>
	<brief_title>Nebivolol Versus Metoprolol : Comparative Effects Fatigue Quality Life</brief_title>
	<detailed_description>- Hypothesis : beta-blocker nebivolol associate less fatigue metoprolol , widely-prescribed beta-blocker - Methods : double-blinded crossover trial compare nebivolol metoprolol . Experimental procedure : Subjects undergo electrocardiogram routine blood testing , unless test perform within 6 month available review . Subjects enter study receive 2 study drug 8 week . Metoprolol succinate give dose 50 mg daily 4 week , 100 mg daily 4 week . For nebivolol , dosage 5 mg 10mg daily . Identical-appearing pill give , drug give randomized order without placebo run-in . At end 4-week treatment period drug , subject undergo treadmill stress test ( use standard Cornell protocol ) , complete Quality Life fatigue questionnaire , blood drawn freeze later analysis drug level . At end 8 week treatment drug , subject undergo echocardiography applanation tonometry ( non-invasive measurement aortic blood pressure ) ass heart function . At end study , blind subject ask 2 study drug prefer , extent energy differ 2 drug . -Rationale : Millions hypertensive patient life-long beta-blocker therapy . In many , reduces cardiac output increase peripheral resistance blood flow ( 1 ) . It well-established beta-blockers cause fatigue many patient reduce exertion tolerance . Every physician know , tacitly accept many patient live unwelcome side effect . A new beta-blocker , nebivolol , standard beta-blocking effect , also produce blood vessel relaxation ( vasodilation ) , probably increase secretion vasodilator nitric oxide . Studies indicate nebivolol , unlike beta-blockers , cause constriction peripheral blood vessel , associate improved heart function ( 2 ) . Studies suggest also less likely cause fatigue ( 3 ) . Personal experience consistent , I observe marked improvement energy patient I prescribe nebivolol place different beta-blocker . The possibility placebo effect course exclude . Nevertheless , know hemodynamic difference nebivolol beta-blockers , positive clinical experience , warrant formal study determine whether nebivolol kinder beta-blockers term important side effect fatigue .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Individuals take , begin take , betablocker , approve indication hypertension Orthopedic ailment would interfere performance treadmill test Stroke heart attack within previous 1 year Symptomatic coronary disease within past year ( angina , shortness breath ) Clinically significant pulmonary disease ( e.g . emphysema asthma ) . Poorly control hypertension ( blood pressure 160 systolic 100 diastolic ) Patients contraindication take betablocker ( asthma bradyarrhythmia ) History tachyarrhythmia ( abnormal rapid heart rate )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>hypertension</keyword>
	<keyword>beta blocker</keyword>
	<keyword>Metoprolol</keyword>
	<keyword>blood pressure , high</keyword>
	<keyword>antihypertensive agent</keyword>
	<keyword>vascular resistance</keyword>
	<keyword>adrenergic beta-receptor blockaders</keyword>
	<keyword>beta-Adrenergic blocker</keyword>
	<keyword>beta-Adrenergic Blocking Agents</keyword>
	<keyword>beta-Adrenergic Receptor Blockaders</keyword>
	<keyword>beta-Blockers , Adrenergic</keyword>
	<keyword>Bystolic</keyword>
	<keyword>Nebivolol</keyword>
	<keyword>Nebivololum</keyword>
	<keyword>Nebivololum [ Latin ]</keyword>
	<keyword>R65,824</keyword>
	<keyword>Beloc- Zok</keyword>
	<keyword>H 93/26 succinate</keyword>
	<keyword>Metoprolol succinate</keyword>
	<keyword>Seloken ZOC</keyword>
	<keyword>Selozok</keyword>
	<keyword>Spesicor Dos</keyword>
	<keyword>Toprol XL</keyword>
	<keyword>Toprol-XL</keyword>
	<keyword>UNII-TH25PD4CCB</keyword>
</DOC>